Retrovirus-like genetic elements and TDP‑43 in Alzheimer's and related dementias

Feedback amplification between Retrotransposons/endogenous retroviruses and TDP-43 in Alzheimers related dementias

NIH-funded research State University New York Stony Brook · NIH-11126666

Researchers are looking at whether virus-like pieces of our DNA and the protein TDP‑43 help Alzheimer's and related dementias spread through the brain.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionState University New York Stony Brook NIH-funded
Lab location1 site (Stony Brook, United States)
Project IDNIH-11126666 on NIH RePORTER

What this research studies

This is a lab project aimed at understanding how a protein called TDP‑43 and mobile genetic elements (retrotransposons/endogenous retroviruses) might amplify and spread damage between brain cells. The team will use fruit fly models and mammalian cells grown in the lab to recreate and track these interactions. By following how these elements become active and move between cells, scientists hope to find steps in the process that could be blocked. This work is preclinical and does not enroll patients directly.

Who could benefit from this research

Good fit: There is no patient enrollment for this lab-based project, so no patients would be eligible to participate.

Not a fit: Patients looking for immediate new treatments or direct involvement should not expect to benefit directly from this basic laboratory research.

Why it matters

Potential benefit: If successful, the work could reveal new biological targets to slow or stop progression of Alzheimer's and related dementias.

How similar studies have performed: Related laboratory studies have linked TDP‑43 and mobile genetic elements in ALS and frontotemporal dementia, but applying this mechanism to Alzheimer's-related dementias is a newer direction.

Where this research is happening

Stony Brook, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAlzheimer's disease and related dementia
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.